Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Fierce Biotech13h
Alphabet's AI biotech Isomorphic Labs hauls in $600M to power next-gen drug design model
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
Alphabet-backed Isomorphic Labs bags $600 million funding to build next-gen AI drug design engine
Isomorphic Labs is raising money in its first-ever external funding round from Thrive Capital, a big backer of ChatGPT ...
Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Tariffs Keep Wall Street on Edge
President Trump’s latest trade war threat is expected to come into effect this week, but businesses and investors remain ...
LiveLaw9hOpinion
A (Cautious) Case For AI In Legal Research
G. K. Chesterton in Miscellany of Men, offers the readers an insight of a modern intellectual (a character in the story) ...